PeptideStack
5.2kquestions
20kanswers
220users

Is a method section from QST sufficient basis to skip independent testing?

Asked 21 Jun 2024Modified 22 months agoViewed 30k times
12

The specifics, since they change the answer: method section · QST.

I am at the decision point and I would rather think it through than improvise.

I would rather spend money on measurement than on redundancy.

What does a sensible plan look like, and what are the decision points?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
shareeditfollowflag
GS
askedgradient_slope41k3821 Jun 2024

5 Answers

Accepted answer first, then by votes
26

Accepted answer

What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.

Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.

The relevant detail is that multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
DL
answered · acceptedDr_Otto_Lindqvist38k382 Oct 2024
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
31

Ask whether the certificate answers the question you are actually asking, because the answer is often no.

The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.

It helps to be literal here: comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
IB
answeredines_brandt93k24827 Jun 2024
22

It helps to be literal here: before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

The part that matters: a method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
C3
answeredcharge_state_339k4814 Oct 2024
13

A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.

Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.

The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
LD
answeredloss_on_drying47k13810 Sept 2024
Useful. I have added the accept threshold suggestion to my own notes. – Dr_Bram_Verhoeven 6 months ago
add a comment
12

Specifically, start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.

Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.

The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
OB
answeredolu_babatunde14k1721 Sept 2024
8Have you seen anything published on this, or is it inference from the mechanism? – unit_math 2 months ago
Useful. I have added the accept threshold suggestion to my own notes. – micron22 4 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.